Pellet formulation for the treatment of the intestinal tract

Details Pellet formulation for the treatment of the intestinal tract Pellet formulation for the treatment of the intestinal tract

2003-02-07

2009-06-16

Hui, San-ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

C424S474000

Reexamination Certificate

active

07547451

ABSTRACT:
An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically tolerable salt or a derivative thereof.

REFERENCES:
patent: 4540685 (1985-09-01), Bauer
patent: 4632921 (1986-12-01), Bauer
patent: 4699902 (1987-10-01), Bauer
patent: 4863744 (1989-09-01), Urquhart et al.
patent: 5178866 (1993-01-01), Wright et al.
patent: 5316772 (1994-05-01), Jurgens, Jr. et al.
patent: 5505966 (1996-04-01), Edman et al.
patent: 5541170 (1996-07-01), Rhodes et al.
patent: 5541171 (1996-07-01), Rhodes et al.
patent: 4236025 (1994-04-01), None
patent: 006200 (1982-10-01), None
patent: 0148811 (1985-07-01), None
patent: 0248447 (1987-12-01), None
patent: 0308665 (1989-03-01), None
patent: 0453001 (1991-10-01), None
patent: 0485840 (1992-05-01), None
patent: 0572486 (1993-12-01), None
patent: 0595110 (1994-05-01), None
patent: 0629398 (1994-12-01), None
patent: 0671168 (1995-09-01), None
patent: 0673645 (1995-09-01), None
patent: 0759303 (1997-02-01), None
patent: 2692484 (1993-12-01), None
patent: 83/00435 (1983-02-01), None
patent: 0148811 (1985-07-01), None
patent: 92/14452 (1992-09-01), None
patent: 93/07859 (1993-04-01), None
patent: 95/16451 (1995-06-01), None
patent: 95/18622 (1995-07-01), None
patent: 95/35100 (1995-12-01), None
patent: 96/04918 (1996-02-01), None
patent: 96/29058 (1996-09-01), None
patent: 96/31202 (1996-10-01), None
patent: 97/23199 (1997-07-01), None
“Dictionary Entries: ‘Mesalamine,’ ‘Proctosigmoiditis’ and ‘Inflammation’”,Stedman's Medical Dictionary, Obtained from the Physician's Desk Reference Electronic Library on the World Wide Web at http://www.pdrel.com/>, on Dec. 17, 1999, 5 p., (1999).
“Dictionary Entry: ‘Pentasa Capsules’ (Mesalamine/5-aminosalicylic Acid)”,Physician's Desk Reference, Obtained from the Physician's Desk Reference Electronic Library on the World Wide Web at http://www.pdrel.com/>, on Dec. 17, 1999, 8 p., (1999).
Badawi, A.A., et al., “Drug Release From Matrices Made of Polymers With Reacting Sites”,International Journal of Pharmaceutics, 6, 55-62, (1980).
Barry, M., “Selected side-effects: 9. Mesalazine and renal impairment”,Prescriber's Journal, vol. 32, No. 5, pp. 205-209, (1992).
Lin, S.Y., et al., “Calcium Alginate Beads as Core Carriers of 5-Aminosalicylic Acid”,Pharmaceutical Research, 9 (9), 1128-1131, (1992).
Watts, P.J., et al., “Encapsulation of 5-aminosalicylic Acid into Eudragit RS Microspheres and Modulation of their Release Characteristics by Use of Surfactants”,Journal of Controlled Release, 16, 311-318, (1991).
“Data Sheets for Registration”,Rohm Brochure, Pharma Polymers, 4 pages.
“U.S. Appl. No. 09/194,213 Final Office Action mailed Sep. 26, 2000”, 7 pgs.
“U.S. Appl. No. 09/194,213 Non Final Office Action mailed Dec. 28, 1999”, 7 pgs.
“U.S. Appl. No. 09/194,213 Notice of Allowance mailed Mar. 30, 2001”, 5 pgs.
“U.S. Appl. No. 09/194,213 Preliminary Amendment filed Nov. 20, 1998”, 2 pgs.
“U.S. Appl. No. 09/194,213 Response filed Mar. 14, 2001 to Final Office Action mailed Sep. 26, 2000”, 5 pgs.
“U.S. Appl. No. 09/194,213 Response filed Jun. 28, 2000 to Non Final Office Action mailed Dec. 28, 1999”, 5 pgs.
“U.S. Appl. No. 09/906,494 Non Final Office Action mailed May 6, 2002”, 7 pgs.
“U.S. Appl. No. 09/906,494 Non Final Office Action mailed Sep. 25, 2001”, 7 pgs.
“U.S. Appl. No. 09/906,494 Notice of Allowance mailed Nov. 4, 2002”, 5 pgs.
“U.S. Appl. No. 09/906,494 Preliminary Amendment filed Jul. 18, 2001”, 4 pgs.
“U.S. Appl. No. 09/906,494 Response filed Aug. 6, 2002 to Non Final Office Action mailed May 6, 2002”, 7 pgs.
“U.S. Appl. No. 09/906,494 Response filed Dec. 28, 2001 to Non Final Office Action mailed Sep. 25, 2001”, 7 pgs.
“U.S. Appl. No. 10/360,410, Response filed Sep. 27, 2007 to Non-Final Office Action mailed May 31, 2007”, 7.

Affiliated with

Also associated with

Rating

Pellet formulation for the treatment of the intestinal tract does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pellet formulation for the treatment of the intestinal tract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pellet formulation for the treatment of the intestinal tract will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4140492